logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Alex Z. Fu

Johnson & Johnson
H指数:32
被引数:4,589

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Healthcare resource utilization and costs in patients with multiple myeloma who received 1 to 3 prior lines of therapy, including a proteasome inhibitor and an immunomodulatory drug, and were exposed to and discontinued lenalidomide in the United States

美国接受1至3线前期治疗（包括蛋白酶体抑制剂和免疫调节药物）并曾使用后停用来那度胺的多发性骨髓瘤患者的医疗资源利用和费用

Journal of Medical Economics
IF3
2025-11-190
OAAI
Sundar Jagannath; Akshay Kharat; Eric Chinaeke; Alex Z. Fu; Matthew Perciavalle; Stephen Huo; Zaina P. Qureshi
Daratumumab, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Meta-Analysis

达鲁单抗、来那度胺和地塞米松与硼替佐米、来那度胺和地塞米松在非移植适用性新诊断多发性骨髓瘤中的应用：一项系统文献综述和荟萃分析

HEMATOLOGICAL ONCOLOGY
IF3.9
2025-04-100
OAAI
Gordan, Lucio N.; Medhekar, Rohan; Fu, Alex Z.; Shokoohi, Mostafa; Oliva Ramirez, Abril; Bonar, Nicolle; Nguyen, Bao-Ngoc; Spence, Michaela; Mctavish, Rebecca; Disher, Tim; Gautam, Santosh; Gupta-Werner, Niodita; Kaila, Shuchita; Patel, Anjan J.
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: Results from the CVD-REAL study

在真实世界的临床实践中，开始使用SGLT2-inhibitors与其他降糖药物治疗的患者的心肌梗死和中风发生率: cvd-real研究的结果

DIABETES OBESITY & METABOLISM
IF5.7
2018-04-1770
OAAI
Kosiborod, Mikhail; Birkeland, Kare I.; Cavender, Matthew A.; Fu, Alex Z.; Wilding, John P.; Khunti, Kamlesh; Holl, Reinhard W.; Norhammar, Anna; Jorgensen, Marit E.; Wittbrodt, Eric T.; Thuresson, Marcus; Bodegard, Johan; Hammar, Niklas; Fenici, Peter
Response by Kosiborod et al to Letters Regarding Article, Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
CIRCULATION
IF38.6
2018-02-273
OAAI
Kosiborod, Mikhail; Cavender, Matthew A.; Fu, Alex Z.; Wilding, John P.; Khunti, Kamlesh; Holl, Reinhard W.; Norhammar, Anna; Birkeland, Kare I.; Jorgensen, Marit Eika; Thuresson, Marcus; Arya, Niki; Bodegard, Johan; Hammar, Niklas; Fenici, Peter
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)
CIRCULATION
IF38.6
2017-07-18661
OAAI
Kosiborod, Mikhail; Cavender, Matthew A.; Fu, Alex Z.; Wilding, John P.; Khunti, Kamlesh; Holl, Reinhard W.; Norhammar, Anna; Birkeland, Kare I.; Jorgensen, Marit Eika; Thuresson, Marcus; Arya, Niki; Bodegard, Johan; Hammar, Niklas; Fenici, Peter

研究方向

暂未获取到该数据
G
Gordon G. Liu
H 指数:38论文数:170被引数:5,373
L
Larry Radican
H 指数:26论文数:119被引数:2,371
S
Shuchita Kaila
H 指数:12论文数:88被引数:571
M
Michael W. Kattan
H 指数:146论文数:1,324被引数:7.6万
K
Kamlesh Khunti
H 指数:162论文数:2,091被引数:11.5万
J
John Wilding
H 指数:95论文数:736被引数:5.6万
R
Reinhard W. Holl
H 指数:93论文数:1,138被引数:3.1万
A
Arnold L. Potosky
H 指数:73论文数:229被引数:2.1万
A
Anna Norhammar
H 指数:51论文数:244被引数:1.5万
K
Kåre I. Birkeland
H 指数:66论文数:373被引数:2.6万